Long-term efficacy and safety of statin treatment beyond six years: A meta-analysis of randomized controlled trials with extended follow-up-Reference-Cited by-同舟云学术

Long-term efficacy and safety of statin treatment beyond six years: A meta-analysis of randomized controlled trials with extended follow-up

Published:2014-03 Issue: Volume:81 Page:64-73
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Lv Han-lu,Jin Dong-mei,Liu Mo,Liu Ying-mei,Wang Jing-feng,Geng Deng-feng

Publisher

Elsevier BV

Subject

Pharmacology

Reference40 articles.

1. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia West of Scotland Coronary Prevention Study Group;Shepherd;N Engl J Med,1995

2. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group;N Engl J Med,1998

3. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90056 participants in 14 randomised trials of statins;Lancet,2005

4. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

5. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;Baigent;Lancet,2010

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Updates in Coronary Artery Disease: A Comprehensive Review;Journal of Clinical Medicine;2024-08-06

2. Landscape of Statin as a Cornerstone in Atherosclerotic Cardiovascular Disease;Reviews in Cardiovascular Medicine;2023-12-29

3. Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-04-15

4. Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol;BMJ Open;2022-04

5. Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants;European Heart Journal;2021-05-08